Stay or Go? Sarah Reynolds at Kensington Partners Custom Case Solution & Analysis

Evidence Brief: Sarah Reynolds at Kensington Partners

1. Financial Metrics and Performance Data

• Individual Track Record: Sarah Reynolds has spent 10 years at Kensington Partners. She is a top-performing Vice President with a track record of sourcing and executing high-margin deals.
• Deal Contribution: She led the acquisition and subsequent turnaround of Medical Solutions, which yielded a 3.5x cash-on-cash return for the fund.
• Compensation Structure: Current compensation includes a base salary, a performance-related bonus, and carried interest in Fund IV and Fund V. The MD promotion would significantly increase her share of the carry pool.
• Firm Assets: Kensington Partners manages approximately 2.5 billion dollars across its current active funds.

2. Operational Facts

• Work Requirements: Standard work weeks for VPs and MDs range from 70 to 80 hours. Frequent travel is required for deal sourcing and board meetings at portfolio companies.
• Firm Hierarchy: The firm is managed by three founding partners. There are 8 MDs, 12 VPs, and a rotating pool of associates.
• Gender Representation: Of the 8 MDs, zero are women. Sarah is the most senior female professional in the investment team.
• Promotion Cycle: MD promotions occur every two years. Missing the current cycle typically results in a four-year delay to the next window or a plateaued career path.

3. Stakeholder Positions

• Sarah Reynolds: Currently pregnant with her second child. She values her career trajectory but identifies a misalignment between the MD role requirements and her family needs.
• David (Managing Partner): Views the MD role as a total-immersion commitment. He values Sarah’s performance but expresses skepticism regarding her ability to maintain intensity while managing a larger family.
• Sarah’s Spouse: Provides support but also maintains a demanding professional career, limiting the feasibility of a primary-caregiver model at home.
• Portfolio Company CEOs: Generally supportive of Sarah, citing her operational expertise as a key value-driver.

4. Information Gaps

• Formal Maternity Policy: The case does not detail a written policy for maternity leave or flexible return-to-work arrangements at the MD level.
• Clawback Provisions: It is unclear if Sarah forfeits unvested carried interest if she resigns before the fund lifecycle ends.
• External Offers: While headhunters have contacted her, the specific financial terms of competing offers (e.g., at a portfolio company) are not quantified.

Strategic Analysis

1. Core Strategic Question

• Can Sarah Reynolds restructure her role at Kensington Partners to align with her life stage, or must she exit the firm to preserve her professional value and personal well-being?
• The dilemma is a choice between pursuing a traditional MD track that risks burnout or seeking a non-traditional path that the firm culture may not support.

2. Structural Analysis

• Value Chain Analysis: Sarah’s primary value to Kensington lies in deal execution and portfolio management. Her move to MD shifts her value-add toward fund-raising and high-level relationship management. Both require high physical presence.
• Jobs-to-be-Done: Kensington needs an MD who can be on call 24/7 to protect investor capital. Sarah needs a role that rewards her 10 years of expertise without requiring 80-hour weeks. These two jobs are currently in direct conflict.
• Porter’s Five Forces: The bargaining power of high-performing VPs in private equity is high due to specialized knowledge. However, the supply of hungry associates willing to work 80 hours creates a substitution threat for Sarah if she demands flexibility.

3. Strategic Options

• Option 1: The Full-Court Press. Sarah seeks the MD promotion immediately, hides the full extent of her family concerns, and attempts to hire significant support (nannies, assistants) to maintain the 80-hour pace.
  • Trade-offs: High financial upside and status; high risk of health issues and family strain.
  • Resources: Significant personal financial investment in domestic support.
• Option 2: The Negotiated Alternative. Sarah proposes a new MD-Lite or Operating Partner role. This role would focus on portfolio optimization rather than new deal sourcing, reducing travel.
  • Trade-offs: Better balance; potential loss of prestige and a lower share of the carry pool.
  • Resources: Requires David’s buy-in and a shift in firm culture.
• Option 3: The Strategic Exit. Sarah resigns to take a C-suite role at a portfolio company or joins a smaller, more flexible mid-market fund.
  • Trade-offs: Immediate relief from PE hours; loss of the Kensington carry and seniority.
  • Resources: Requires a strong external network and a clean break from current vesting schedules.

4. Preliminary Recommendation

• Sarah should pursue Option 3: The Strategic Exit. The cultural DNA of Kensington Partners, as evidenced by David’s stance and the lack of female MDs, is resistant to the flexibility Sarah requires. Attempting to change the firm while pregnant with a second child is a low-probability success strategy. Moving to a portfolio company allows her to apply her expertise in a more controlled, operational environment.

Implementation Roadmap

1. Critical Path

• Phase 1: Inventory and Legal Review (Weeks 1-2). Review the partnership agreement. Determine the exact status of vested versus unvested carry. Identify any non-compete clauses that restrict a move to a portfolio company.
• Phase 2: Market Testing (Weeks 3-6). Discreetly engage with trusted headhunters to value her market worth in COO or CEO roles. Prioritize roles within the current fund’s portfolio where she has already built equity with the management teams.
• Phase 3: The Final Negotiation (Weeks 7-8). Present a proposal for the MD role with specific flexibility requirements to David. This is a diagnostic move; his reaction will confirm if an internal path exists.
• Phase 4: Exit Execution (Weeks 9-12). If the negotiation fails, as expected, submit a resignation with a clear transition plan for her current deals to ensure she leaves on good terms.

2. Key Constraints

• Cultural Inertia: The founding partners view presence as a proxy for commitment. Sarah cannot overcome this bias through performance alone.
• Timing: The pregnancy creates a hard deadline for the transition. Any move must be finalized before her third trimester to ensure a stable start in a new role.

3. Risk-Adjusted Implementation Strategy

• The primary risk is the loss of unvested carry. Sarah should negotiate a consulting arrangement for the transition period to bridge the gap toward vesting milestones. If David reacts punitively, Sarah must be prepared to walk away immediately to protect her reputation and health, viewing the lost carry as the cost of career pivot.

Executive Review and BLUF

1. BLUF

Sarah Reynolds must exit Kensington Partners. The firm’s operating model is fundamentally incompatible with her current life stage. The Managing Partner’s definition of the Managing Director role requires 80-hour weekly availability and constant travel, a standard that Sarah cannot and should not meet given her second pregnancy. Remaining at the firm to fight for a cultural shift will lead to burnout and a likely failed promotion. She should leverage her success with Medical Solutions to secure a C-suite role at a portfolio company. This move preserves her professional standing, provides better operational control, and eliminates the toxic requirement of performative overwork. Speed is essential; she must secure her next role before her third trimester to maintain maximum negotiating power.

2. Dangerous Assumption

The analysis assumes Sarah can negotiate a clean exit while retaining her reputation. In the small world of private equity, a mid-pregnancy exit can be unfairly framed as a lack of ambition. This bias could impact her ability to secure a portfolio company role if the Kensington partners control the board of that company.

3. Unaddressed Risks

• Vesting Risk: If Sarah exits now, she likely leaves 40 to 60 percent of her projected net worth on the table in the form of unvested carry. The financial consequence is a permanent reduction in lifetime earnings.
• Market Timing Risk: If the private equity market cools during her transition, portfolio companies may freeze hiring, leaving her without a landing spot during her maternity leave.

4. Unconsidered Alternative

The team failed to consider a sabbatical. Sarah could propose a six-month unpaid leave of absence to reset, followed by a return in a senior advisor capacity. This would allow Kensington to keep her expertise on the books without the immediate pressure of an MD promotion, effectively kicking the decision down the road until after her child is born.

5. MECE Assessment

• Stay: Pursue MD (High Risk), Stay as VP (Stagnation).
• Go: To Competitor (Same Problem), To Portfolio Company (Better Alignment), To Independent Consulting (High Flexibility, Lower Income).
• Wait: Sabbatical (Temporary Relief).

VERDICT: APPROVED FOR LEADERSHIP REVIEW